| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.63M | 12.26M | 6.51M | 2.42M | 1.90M |
| Gross Profit | 7.10M | 5.72M | 2.95M | 1.35M | 884.91K |
| EBITDA | 537.86K | 750.42K | -405.12K | -914.93K | -914.04K |
| Net Income | -151.13K | -160.04K | -1.04M | -1.43M | -1.66M |
Balance Sheet | |||||
| Total Assets | 6.68M | 6.76M | 6.39M | 5.40M | 5.41M |
| Cash, Cash Equivalents and Short-Term Investments | 1.39M | 2.20M | 1.18M | 377.17K | 103.61K |
| Total Debt | 3.79M | 4.63M | 5.56M | 6.23M | 5.76M |
| Total Liabilities | 10.59M | 10.52M | 10.02M | 8.22M | 8.54M |
| Stockholders Equity | -3.90M | -3.76M | -3.63M | -2.83M | -3.12M |
Cash Flow | |||||
| Free Cash Flow | -14.49K | 1.90M | 1.12M | -1.21M | -1.04M |
| Operating Cash Flow | 29.19K | 1.96M | 1.13M | -1.19M | -1.04M |
| Investing Cash Flow | -43.68K | -58.18K | -14.54K | -11.28K | 0.00 |
| Financing Cash Flow | -790.41K | -887.07K | -313.13K | 1.48M | 1.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £2.84M | 8.11 | 6.74% | ― | 1.64% | ― | |
67 Neutral | £7.04M | 16.58 | 15.40% | ― | 6.46% | -32.89% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £6.36M | 74.29 | ― | ― | 31.39% | ― | |
52 Neutral | ― | ― | ― | ― | -44.60% | 70.63% |
Malvern International announced that its CEO, Richard Mace, sold and repurchased 102,508 ordinary shares, maintaining his total shareholding. This transaction, conducted on the London Stock Exchange, reflects a strategic financial move without altering Mace’s overall stake in the company, suggesting stability in leadership commitment.
The most recent analyst rating on (GB:MLVN) stock is a Hold with a £18.00 price target. To see the full list of analyst forecasts on Malvern International stock, see the GB:MLVN Stock Forecast page.
Malvern International PLC announced that its CEO, Richard Mace, has sold and repurchased the same number of shares, maintaining his total shareholding. This transaction, involving the transfer of shares to his SIPP, reflects a strategic financial decision without altering his overall stake in the company.
The most recent analyst rating on (GB:MLVN) stock is a Hold with a £18.00 price target. To see the full list of analyst forecasts on Malvern International stock, see the GB:MLVN Stock Forecast page.
Malvern International PLC reported a 25% increase in revenues to £6.36m for the first half of 2025, driven by a rise in student numbers at the University of East London. The company also secured new university partnership contracts with the Universities of Cumbria and Wolverhampton, and a five-year partnership with Liverpool Hope University, which is expected to enhance its growth prospects. Malvern’s strategic focus on expanding its university partnerships and improving sales and marketing efforts aims to transform the company into a larger business with a diverse revenue stream, contributing to its profitability and market positioning.
The most recent analyst rating on (GB:MLVN) stock is a Hold with a £17.00 price target. To see the full list of analyst forecasts on Malvern International stock, see the GB:MLVN Stock Forecast page.
Malvern International PLC has announced a change in its financial reporting date from 31 December to 30 September, aligning it with the UK university academic year. This adjustment aims to provide a clearer assessment of the company’s performance, particularly in its rapidly growing University Partnerships sector, allowing for more accurate forecasting and better alignment with student intake cycles.
The most recent analyst rating on (GB:MLVN) stock is a Hold with a £16.50 price target. To see the full list of analyst forecasts on Malvern International stock, see the GB:MLVN Stock Forecast page.